-
2024-517215-67-00
5
2021-06-11
Newly diagnosed Non-Frail transplant Ineligible Multiple Myeloma elder
-
2024-513427-17-00
6
2021-05-20
Well controlled severe allergic asthma
-
2024-514025-30-00
4
2021-03-25
Ocular conservative treatment for retinoblastoma
-
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
-
2024-517288-22-01
6
2021-01-29
Lymphoma
-
2022-502642-27-00
9
2020-11-26
RElapse in previously irradiated Prostate bed
-
2023-508469-34-00
1
2020-10-14
Esophageal cancer
-
2022-501456-28-00
5
2020-07-20
atypical teratoid/rhabdoid tumours (ATRT)
-
2024-513248-27-00
5
2020-07-20
Patients, men or women over 18 old, with inoperable vertebral bone met
-
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
-
2024-517841-16-00
6
2020-07-09
Neurogenic Orthostatic Hypotension
-
2024-511904-18-00
10
2020-07-08
Pancreatic adenocarcinoma (PAC)
-
2024-515276-12-00
5
2020-07-01
Postpartum Hemorrhage
-
2024-515584-56-00
5
2020-06-19
Cutibacterium acnes infection in shoulder arthroplasty with males
-
2023-510567-35-00
4
2020-06-10
Advanced / metastatic cancers
-
2024-514603-34-00
5
2020-03-02
intermediate-risk differentiated thyroid cancer patients
-
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
-
2023-508926-91-00
5
2019-12-05
Stage IV childhood renal tumour with pulmonary +/- non-pulmonary
metas
-
2023-507689-26-00
5
2019-10-07
Histologically or cytologically confirmed Locoregional Hepatocellular
-
2024-514156-33-00
5
2019-08-20
Patients in remission for granulomatosis with polyangiitis (GPA,
Wegen
-
2024-511862-35-00
4
2019-07-19
Adults with non-contrast-enhancing diffuse brainstem gliomas with non-
-
2024-510580-28-00
5
2019-06-05
Middle or low locally advanced resectable rectal carcinoma
-
2024-512173-27-00
5
2019-03-21
Advanced (stage IIIB/IIIC/IV) NSCLC patients eligible for treatment wi
-
2024-512034-14-00
5
2019-03-04
severe trauma